Julia Brncic
About Julia Brncic
Julia Brncic (age 51) serves as General Counsel and Secretary at EverQuote (EVER), a role she has held since January 2023. She previously served as SVP, Chief Counsel and Corporate Secretary at The Cigna Group (2018–2022) and Vice President/Deputy General Counsel at Express Scripts (2008–2018), and was a shareholder at Polsinelli; she holds J.D. and M.B.A. degrees from Washington University in St. Louis and a B.A. from Purdue University . Company performance context during her tenure includes negative net income and depressed TSR through 2023, with the company’s pay-versus-performance disclosure emphasizing TSR and net loss; management notes it does not use TSR or net loss as compensation metrics .
Company performance snapshot (per Pay vs. Performance disclosure):
| Metric | 2021 | 2022 | 2023 |
|---|---|---|---|
| Value of $100 Investment (TSR) | $41.93 | $39.46 | $32.77 |
| Net Income/(Loss) ($000s) | $(19,434) | $(24,416) | $(51,287) |
Past Roles
| Organization | Role | Years | Strategic Impact / Notes |
|---|---|---|---|
| The Cigna Group | SVP, Chief Counsel & Corporate Secretary | Dec 2018 – May 2022 | Top legal/governance role at global health company |
| Express Scripts, Inc. | Vice President & Deputy General Counsel | Sep 2008 – Dec 2018 | Senior legal leadership at major PBM |
| Polsinelli | Shareholder | Prior to 2008 | Law firm partner-level experience |
Fixed Compensation
| Component | 2023 Actual | Current/Target Terms |
|---|---|---|
| Base Salary | $294,231 | $375,000 current base per offer letter |
| Target Annual Bonus | — | $225,000 target (discretionary, tied to agreed targets) |
| Non-Equity Incentive (Paid) | $37,500 | Special one-time $100,000 cash bonus eligible if specified 2024 goal achieved |
| All Other Compensation | $506 | Standard employee benefits (401k match, life insurance, parking) |
Notes:
- At-will employment; start date January 9, 2023 .
- Non-compete 18 months; non-solicit 24 months post-termination; perpetual confidentiality .
Performance Compensation
Summary (2023 NEO compensation disclosure):
| Component | 2023 Amount |
|---|---|
| Stock Awards (Grant-Date Fair Value) | $955,725 |
| Option Awards (Grant-Date Fair Value) | $738,411 |
Key 2023 equity grants and vesting:
| Grant | Shares/Options | Exercise Price | Expiration | Vesting |
|---|---|---|---|---|
| RSU (2/17/2023) | 42,500 RSUs | — | — | 25% after 12 months from 2/15/2023, then equal quarterly over 3 years |
| Stock Option (2/17/2023) | 53,000 unexercisable options | $15.81 | 2/16/2033 | 25% after 12 months from 2/15/2023, then equal quarterly over 3 years |
| RSU (7/24/2023) | 37,500 RSUs | — | — | Equal quarterly over 4 years from 1/1/2024 (company footnote schedules) |
| Stock Option (7/24/2023) | 625 exercisable / 9,375 unexercisable | $7.10 | 7/23/2033 | Equal quarterly over 4 years from 8/20/2023 |
| Stock Option (7/24/2023) | 2,537 exercisable / 17,761 unexercisable | $7.10 | 7/23/2033 | Equal quarterly over 2 years from 8/20/2023 |
Incentive plan metrics: EverQuote states the executive bonus plan is based on agreed-upon targets (not itemized) and that the compensation committee does not use TSR or net loss as performance measures; CAP is not used for compensation decisions .
Equity Ownership & Alignment
Beneficial ownership as of April 8, 2024:
| Holder | Shares Beneficially Owned | % of Class | Notes |
|---|---|---|---|
| Julia Brncic | 43,400 | <1% | As of 4/8/2024; address c/o EverQuote |
Breakdown of outstanding equity (as of 12/31/2023):
| Type | Quantity | Market/Terms |
|---|---|---|
| Unvested RSUs | 42,500 (2/17/2023) ; 37,500 (7/24/2023) | Market value disclosed for RSUs in severance tables uses $12.24 per share on 12/29/2023 |
| Stock Options (exercisable) | 625 @ $7.10; 2,537 @ $7.10 | Expire 7/23/2033 |
| Stock Options (unexercisable) | 53,000 @ $15.81 [2/16/2033] ; 9,375 @ $7.10; 17,761 @ $7.10 [7/23/2033] | Vesting per schedules above |
Moneyness snapshot (12/29/2023 close $12.24): $7.10 options are in-the-money; $15.81 options are out-of-the-money at that reference date .
Ownership policy and hedging:
- Stock ownership guidelines (adopted Feb 2022): CEO 5x base salary; other NEOs 1x base salary; 5-year compliance period; subject to phase-in, directors/CEO/other NEOs are currently compliant .
- Anti-hedging policy prohibits short sales, derivative transactions, and instruments designed to offset decreases in stock value .
- Rule 10b5-1 plans may be used by directors and officers (policy described) .
- No specific pledging policy disclosure identified in the cited materials.
Employment Terms
Severance and change-in-control economics (as of 12/31/2023):
| Scenario | Cash Severance | Benefits Continuation | Acceleration Value |
|---|---|---|---|
| Termination without cause/for good reason in connection with a Change in Control | $300,000 (12 months base) | $28,670 | $520,200 (aggregate market value of unvested RSUs at $12.24) |
| Other Qualifying Termination (no Change in Control) | $150,000 (6 months base) | $14,335 | $256,296 (aggregate market value of unvested RSUs at $12.24) |
Additional terms:
- At-will; offer letter dated Dec 23, 2022; employment start Jan 9, 2023 .
- Restrictive covenants: confidentiality (perpetual), non-solicit (24 months), non-compete (18 months) .
- Clawback policy adopted per Nasdaq standards, applicable to incentive-based compensation received on/after Oct 2, 2023 .
Compensation Structure Analysis
- Mix and risk: 2023 equity awards are time-based RSUs and stock options with service-based vesting; no performance share units for Brncic are disclosed, which reduces explicit linkage of equity vesting to operating/market metrics for her awards .
- Bonus metrics: Executive bonus plan is discretionary and based on agreed targets; specific metrics/weights not disclosed for Brncic .
- Governance controls: Anti-hedging policy in place; clawback policy adopted; equity grant timing generally on fixed schedules, with no option timing around MNPI per policy discussion .
Vesting Schedules and Potential Selling Pressure
- RSUs: 2/17/2023 RSUs vest 25% at 12 months (2/15/2024) and quarterly over the next 3 years; 7/24/2023 RSUs vest in equal quarterly installments over 4 years from 1/1/2024—implying steady quarterly share deliveries through 2027–2028 depending on schedule specifics .
- Options: 7/24/2023 options vest quarterly over 4 years (and a separate grant over 2 years), creating additional quarterly vesting; $7.10 tranches were in-the-money at the 12/29/2023 close, which can create exercise/sale windows during open trading periods or under 10b5-1 plans .
Performance & Track Record
- Corporate actions and filings: Brncic has signed multiple 8-Ks and earnings materials as Secretary and General Counsel (e.g., 2023–2025 earnings/press 8-Ks), indicating a central role in disclosure and transaction execution .
- Transaction involvement: Her contact details are listed in the MyPlanAdvocate sale agreement exhibit, indicating deal counsel coordination responsibilities .
- Pay-versus-performance context: Company’s CAP/TSR and net income trends through 2023 are disclosed; the committee notes CAP is not used for pay-setting and TSR/net loss are not formal performance measures .
Compensation Committee, Consultants, Peer Group, and Say-on-Pay
- Compensation committee engages independent consultant (Compensia, Inc.) for benchmarking and peer selection; independence reviewed; no conflicts noted .
- Example peer group used for 2021 compensation decisions includes marketplace/tech names (e.g., CarGurus, PagerDuty, Yext, Upwork) .
- Say-on-Pay: 96.9% approval at 2021 Annual Meeting .
Investment Implications
- Alignment and exposure: Brncic’s direct beneficial ownership is modest (<1%), but she holds meaningful unvested RSUs and options with steady quarterly vesting, which aligns value creation with service continuity and stock price, while creating periodic supply from vesting/settlements .
- Retention and protections: Non-compete (18 months) and non-solicit (24 months) reduce transition risk; severance is moderate (6–12 months base), with double-trigger equity acceleration under change in control—reasonable market terms without gross-ups disclosed .
- Trading/overhang risk: In-the-money options at $7.10 and ongoing quarterly RSU vesting could contribute to intermittent selling pressure during open windows or via 10b5-1 plans; anti-hedging constraints and a clawback policy enhance governance .
- Pay-for-performance: For Brncic specifically, equity awards are time-based rather than performance-based; bonus metrics are not disclosed—limiting transparency on her pay-performance linkage, though overall company disclosures articulate performance frameworks and governance processes .